Jasper Therapeutics Statistics
Total Valuation
JSPR has a market cap or net worth of $82.47 million. The enterprise value is $36.26 million.
Important Dates
The next estimated earnings date is Tuesday, August 12, 2025, before market open.
| Earnings Date | Aug 12, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
JSPR has 15.02 million shares outstanding. The number of shares has increased by 29.64% in one year.
| Current Share Class | 15.02M |
| Shares Outstanding | 15.02M |
| Shares Change (YoY) | +29.64% |
| Shares Change (QoQ) | +0.09% |
| Owned by Insiders (%) | 1.27% |
| Owned by Institutions (%) | 55.95% |
| Float | 9.91M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 1.95 |
| P/TBV Ratio | 1.95 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.31, with a Debt / Equity ratio of 0.06.
| Current Ratio | 4.31 |
| Quick Ratio | 3.96 |
| Debt / Equity | 0.06 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -101.34% and return on invested capital (ROIC) is -64.57%.
| Return on Equity (ROE) | -101.34% |
| Return on Assets (ROA) | -56.50% |
| Return on Invested Capital (ROIC) | -64.57% |
| Return on Capital Employed (ROCE) | -183.30% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.23M |
| Employee Count | 64 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -73.83% in the last 52 weeks. The beta is 2.72, so JSPR's price volatility has been higher than the market average.
| Beta (5Y) | 2.72 |
| 52-Week Price Change | -73.83% |
| 50-Day Moving Average | 5.13 |
| 200-Day Moving Average | 11.76 |
| Relative Strength Index (RSI) | 52.25 |
| Average Volume (20 Days) | 343,781 |
Short Selling Information
The latest short interest is 1.54 million, so 10.27% of the outstanding shares have been sold short.
| Short Interest | 1.54M |
| Short Previous Month | 1.73M |
| Short % of Shares Out | 10.27% |
| Short % of Float | 15.57% |
| Short Ratio (days to cover) | 6.99 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -82.97M |
| Pretax Income | -63.93M |
| Net Income | -78.78M |
| EBITDA | -81.61M |
| EBIT | -82.97M |
| Earnings Per Share (EPS) | -$5.25 |
Full Income StatementBalance Sheet
The company has $48.80 million in cash and $2.59 million in debt, giving a net cash position of $46.21 million or $3.08 per share.
| Cash & Cash Equivalents | 48.80M |
| Total Debt | 2.59M |
| Net Cash | 46.21M |
| Net Cash Per Share | $3.08 |
| Equity (Book Value) | 42.24M |
| Book Value Per Share | 2.81 |
| Working Capital | 40.84M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$69.71 million and capital expenditures -$527,000, giving a free cash flow of -$70.24 million.
| Operating Cash Flow | -69.71M |
| Capital Expenditures | -527,000 |
| Free Cash Flow | -70.24M |
| FCF Per Share | -$4.68 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
JSPR does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -29.64% |
| Shareholder Yield | -29.64% |
| Earnings Yield | -95.53% |
| FCF Yield | -85.16% |
Analyst Forecast
The average price target for JSPR is $62.22, which is 1,033.33% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $62.22 |
| Price Target Difference | 1,033.33% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 10 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | -15.95% |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on January 4, 2024. It was a reverse split with a ratio of 0.1:1.
| Last Split Date | Jan 4, 2024 |
| Split Type | Reverse |
| Split Ratio | 0.1:1 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |
